This page contains a Flash digital edition of a book.

abelling Solutions

C ear cons umer in format on :ormation:i The gr wing importance of the role of packaging

Clear consumer infl

The growing importance of the role of packaging and labelling in the pharmaceuticals industryand labelling in the pharmaceuticals industr

EssentraEssentr O Fa

crucialmedicat ke

theEuropean industryrecent

inclusionof serialisation aveasignifican

egislat at

However, co

radiscusseshowmanufa ationusage informat


neof themost talked-about topics in anpharmaceuticals ntlyhasbeentheEU


FalsifiedMedicinesDirective.Directly addressing the threat medicines, the leg

atof counterfe ationwill enfo


andtamper evident force the

featuresonpharmaceuticalpackag ng willhav

r, despite the challenges that

manufacturersmay face in implementing the new regulations – such as altering their packaging, IT systems and supply chain management – it is vital that the transition for consumers remains smooth. In particular, manufacturersmust not compromise the user experience or hinder patient adherence. Patient adherence is the extent to which a person’s behaviour – for example, taking medication – corresponds with agreed

recommendations froma health care provider.r. Alarmingly, approximately 50 per cent of patients with chronic disea ses in developed countries do not takemedications as prescribed, and this figure is said to be even higher in developing countries.


According to theWorld Health Organisation, one of the factors that contributes to poor adherence is a lack of knowledge, as patients oftenmisunderstand treatment instructions. Pharmaceutical packaging therefore plays an incredibly important role, given the information it provides that helps patients abide by the proper dosing schedule.

Packaging can influence patient adherence inmanyways, fromthe infoformation it

agingand ficant impactonthe industry.y.

facturers canmake it easier fo ationwh

carries to the overall design and ease of use fofor the consumer.

r. Such

infoformation should be conveyed in away that is clear and easy to understand, and delivery of which can be enhanced by the available space to communicate these details.

Patient instructions and drug information are conveyed through multiple formats – printing onto cartons, leaflets inserted into cartons, printing onto blister packs, or through the use of labels whichmay be applied to primary pharmaceutical packagin g, such as a bottle.

THE NEED ORMORE INFORMATION There is currently a trend in long form instructions, wherebymore information is required on a pack alongside variations of it, for example providing the same information in different languages or using graphics as well as words to help the consumer navigate to the information they need to know.


Several solutions are available to increase the amount of space available to deliver additional information inmore understandable ways. Fo Essentra’s Pluriumis a booklet style t is easier for users to access thanmap ions. The pages work like those of a


style vers leaflet tha example,

book, which also allows pharmaceutical companies to design around the pages to improve content navigation. As with other available leaflet options, Pluriumfits into

standard packs,meaningmanufacturers do not need to change their existing carton designs. Labels are also an area for innovation in the delivery of patient information, where they can be opened or extended to revealmore space. Essentra’s Extended Content Labels are an eficient way to achieve this onmedicine bottles, allowing patients to open the label like a booklet and access further details. The front panel can reveal brandingmessages, while insid e pharmaceutical companies faces on which to print and usage and product information.


convey additional can have up to 32

Peelable labels also offermore space; fofor

example, Essentra’s ‘Peel 2 Read’ labels can be two- y, and are straightfoforward peel-back

or three-ply,

labels that allowfor extended text on the pack. As pharmaceutical companies look to provide more detail on product warnings, dosage

instructions, legal infoformation and ingredients, it is clear that packagingmust work to support patient adherence.With the EU FalsifiedMedicine s Directive coming into place in 2017,

7, the likelihood

that patients will receive the correctmedication should increase – and pharmaceuticals

companies nowmust ensure that consumers take these authentic products correctly.

y. www. 30 September 2016 while alsomeetingnew eg

for consumers toaccess ewregulations

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40